Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Cancer Experts Offer Healthy Dose of Skepticism Toward Hype Over Antiangiogenesis Agents

Article Abstract:

Cancer specialists are skeptical that antiangiogenesis agents will be the ultimate cure for cancer. These compounds inhibit the development of new blood vessels, important for tumors to establish a blood supply and grow. Research in mice has shown that angiostatin and endostatin, both antiangiogenesis agents, can eliminate cancer. These compounds have not yet been tested in humans, and researchers expect they will not live up to the claims published widely in the media. Such agents may impair wound healing, yet they may be useful in combination with other anticancer drugs.

Author: Phillips, Pat
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Conferences, meetings and seminars, Neovascularization, Endostatin, American Society of Clinical Oncology, Angiostatin

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Mixed Response to New PSA Screening Study

Article Abstract:

The findings of a large study of prostate cancer indicate that screening with the prostate-specific antigen (PSA) blood test may save lives by catching the disease early. The eight-year, prospective study of 46,193 men determined that deaths from prostate cancer were 69% less common in men who took the PSA test. The study author recommends annual PSA testing in men starting at 50 years of age, and after age 40 for African-American and other men at high risk for prostate cancer. Some researchers have questioned the methods used in the study.

Author: Phillips, Pat
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Prostate cancer, Medical screening, Health screening, Prostate-specific antigen, Prostate specific antigen

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Therapies directed against epidermal growth factor receptor in Aerodigestive carcinomas

Article Abstract:

A study of cancers from aerodigestive epithiluim and carcinomas of the head, neck and lung and esophegus was conducted and the role of epidermal growth factor receptors (EGFR) was evaluated. Results concluded that EGFR is a promising therapy against cancer.

Author: Karamouzis, Michalis V., Grandis, Jennifer R., Argiris, Athanassios
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
United States, Science & research, Dosage and administration, Epidermal growth factor receptors, Carcinoma, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Prevention, Drug therapy, Cancer
Similar abstracts:
  • Abstracts: An African perspective. Health emergencies in large populations
  • Abstracts: Magic number: investing the accuracy of calorie readouts on cardiovascular fitness machines. Class struggle
  • Abstracts: Trends in Medicare payments in the last year of life. Putting power into patient choice. Medicare policy for future generations - a search for a permanent solution
  • Abstracts: The dating game. Ankles: a twist of fate: sprains, strains and other bad turns. Twist & shout
  • Abstracts: The cost of infertility. Speaking out. The mother of all questions
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.